RARA CRAFT DATABASE for FDA Medical Devices
510(k)K220215

FDA DEVICE FACTS

Powder Free Nitrile Examination Glove, Non-sterile, Tested for Use with Chemotherapy Drugs, and the Opioid Fentanyl citrate, simulated Gastric Acid, and Fentanyl in Gastric Acid (Blue)

Ksg Medicare Sdn. Bhd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 26, 2022PRODUCT CODELZA

Indications for use

A Nitrile powder free examination glove is a disposable device intended for medical purposes, worn on the examiner's hand or finger to prevent contamination between examiner and patient. This specialty glove has also been tested for use with Chemotherapy Drugs and the Opioid Fentany] citrate, simulated Gastric Acid and Fentanyl in Gastric Acid. Gloves were tested for Permeation Breakthrough Resistance in accordance with ASTM D6978 testing with the Chemotherapy Drugs listed below Chemotherapy Drug Concentration Minimum ; ; Tested Breakthrough Detection Time Carboplatin 10.0mg/ml | No breakthrough up to 240 minutes Carmustine (BCNU) 3.3mg/ml 23.6 minutes Cisplatin 1.0mg/ml | No breakthrough up to 240 minutes Cytarabine HCL 100.0mg/ml | No breakthrough up to 240 minutes Cyclophosphamide (Cytoxan) 20.0mg/ml | No breakthrough up to 240 minutes Dacarbazine (DTIC) 10.0mg/ml | No breakthrough up to 240 minutes Docetaxel 10.0mg/ml | No breakthrough up to 240 minutes Doxorubicin Hydrochloride 2.0rmg/ml | No breakthrough up lo 240 minutes Etoposide (Toposar) 20.0mg/ml | No breakthrough up to 240 minutes Fluorouracil 50.0mg/ml | No breakthrough up to 240 minutes Gemcitabine 38.0mg/ml | No breakthrough up to 240 minutes lfosfamide 50.0mg/ml | No breakthrough up to 240 minutes Irinotecan 20.0mg/ml | No breakthrough up to 240 minutes Mechlorethamine 1.0mg/ml | No breakthrough up to 240 minutes Melphalan 5.0mg/ml | No breakthrough up to 240 minutes Methotrexate 25.0mg/ml | No breakthrough up to 240 minutes Mitomycin C 0.5mg/ml | No breakthrough up to 240 minutes Mitoxantrone 2.0mg/ml | No breakthrough up to 240 minutes Paclitaxel (Taxol) 6.0mg/ml | No breakthrough up to 240 minutes ThioTepa 10.0mg/ml 57.8 minutes Vincristine Sulfate 1.0mg/ml | No breakthrough up to 240 minutes Important: Carmustine and ThioTepa have extremely low minimal breakthrough times of 23.6 minutes and 57.8 minutes respectively. Warning: Do not use with Carmustine or ThioTepa _ Concentration Minimum Breakthrough Detection Opioid Drug . Tested Time Fentanyl citrate (injectable) 100mcg/2ml No breakthrough up to 240 minutes Gastric Acid (simulated) 0.2%NaCl in 0.7 HCL | No breakthrough up to 240 minutes Fentanyl in Gastric Acid 50/50 mix No breakthrough up to 240 minutes Please Note: Gloves used for protection against possible Chemotherapy Drug exposure should be selected specifically for the type of drugs used. Users should review the drug labeling or material data sheets for the drug being used to determine an adequate level of protection.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026